Loading...
Uploaded by PharmaTVChannel on Nov 8, 2011
Kevin Johnson, Partner at Index Ventures discusses their early stage investments and single asset companies with Fintan Walton
Science & Technology
Standard YouTube License
Some excellent insights from Kevin on the industry and how it is changing but still offers huge benefits.
biotechheads 3 weeks ago
Load more suggestions
Some excellent insights from Kevin on the industry and how it is changing but still offers huge benefits.
biotechheads 3 weeks ago